Erectile Function Durability Following Permanent Prostate Brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 3, 2009, Pages 639-648

  Taira, Al V ^a   Merrick, Gregory S ^b   Galbreath, Robert W ^b   Butler, Wayne M ^b   Wallner, Kent E ^c   Kurko, Brian S ^b   Anderson, Richard ^b   Lief, Jonathan H ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b WHEELING JESUIT UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Brachytherapy; Erectile Function; Prostate cancer; Proximal penis

Indexed keywords

BRACHYTHERAPY; COX REGRESSION ANALYSIS; DOSIMETRIC PARAMETER; ERECTILE FUNCTION; LONG-TERM CHANGES; MECHANICAL SUPPORT; PROSPECTIVE RANDOMIZED TRIAL; PROSTATE BRACHYTHERAPY; PROSTATE CANCER; PROSTATE CANCERS; PROSTATE SIZE; PROXIMAL PENIS;

REGRESSION ANALYSIS; SUGAR (SUCROSE);

PATIENT REHABILITATION;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DIABETES MELLITUS; DOSIMETRY; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PENIS ERECTION; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; TREATMENT OUTCOME;

AGE FACTORS; AGED; ANALYSIS OF VARIANCE; BRACHYTHERAPY; CHI-SQUARE DISTRIBUTION; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; PENILE ERECTION; PENIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RECOVERY OF FUNCTION; TIME FACTORS;

EID: 70349560041     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.11.058     Document Type: Article

References (30)

1. Wilt T.J., MacDonald R., Rutks I., et al. Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 148 (2008) 435-448
2. Sanda M.G., Dunn R.L., Michalski J., et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358 (2008) 1250-1261
3. Talcott J.A., Manola J., Clark J.A., et al. Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol 21 (2003) 3979-3986
4. Robinson J.W., Moritz S., and Fung T. Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. Int J Radiat Oncol Biol Phys 54 (2002) 1063-1068
5. Merrick G.S., Butler W.M., Wallner K.E., et al. Erectile function after prostate brachytherapy. Int J Radiat Oncol Biol Phys 62 (2005) 437-447
6. Stock R.G., Kao J., and Stone N.N. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 165 (2001) 436-439
7. Rosen R.C., Riley A., Wagner G., et al. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 49 (1997) 822-830
8. Wallner K., Merrick G., True L., et al. 125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial. Int J Radiat Oncol Biol Phys 57 (2003) 1297-1303
9. Wallner K., Merrick G., True L., et al. 20 Gy versus 44 Gy supplemental beam radiation with Pd-103 prostate brachytherapy: Preliminary biochemical outcomes from a prospective randomized multi-center trial. Radiother Oncol 75 (2005) 307-310
10. Merrick G.S., Wallner K., Butler W.M., et al. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys 50 (2001) 597-604
11. Wallner K.E., Merrick G.S., Benson M.L., et al. Penile bulb imaging. Int J Radiat Oncol Biol Phys 53 (2002) 928-933
12. Dubbelman Y.D., Dohle G.R., and Schroder F.H. Sexual function before and after radical retropubic prostatectomy: A systematic review of prognostic indicators for a successful outcome. Eur Urol 50 (2006) 711-718 discussion 718-720
13. Mulhall J., Ahmed A., Parker M., et al. The hemodynamics of erectile dysfunction following external beam radiation for prostate cancer. J Sex Med 2 (2005) 432-437
14. Zelefsky M.J., and Eid J.F. Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer. Int J Radiat Oncol Biol Phys 40 (1998) 129-133
15. Montorsi F., Briganti A., Salonia A., et al. Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol 45 (2004) 123-133
16. Kiteley R.A., Lee W.R., deGuzman A.F., et al. Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy. Brachytherapy 1 (2002) 90-94
17. Merrick G.S., Butler W.M., Dorsey A.T., et al. A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys 48 (2000) 1069-1074
18. Wright J.L., Newhouse J.H., Laguna J.L., et al. Localization of neurovascular bundles on pelvic CT and evaluation of radiation dose to structures putatively involved in erectile dysfunction after prostate brachytherapy. Int J Radiat Oncol Biol Phys 59 (2004) 426-435
19. Mangar S.A., Sydes M.R., Tucker H.L., et al. Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: Using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397). Radiother Oncol 80 (2006) 355-362
20. Merrick G.S., Butler W.M., Wallner K.E., et al. The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction. Int J Radiat Oncol Biol Phys 54 (2002) 1055-1062
21. Roach M., Winter K., Michalski J.M., et al. Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: Findings from a prospective, multi-institutional, phase I/II dose-escalation study. Int J Radiat Oncol Biol Phys 60 (2004) 1351-1356
22. Macdonald A.G., Keyes M., Kruk A., et al. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: Is dose to the penile bulb important?. Int J Radiat Oncol Biol Phys 63 (2005) 155-163
23. van der Wielen G.J., Hoogeman M.S., Dohle G.R., et al. Dose-volume parameters of the corpora cavernosa do not correlate with erectile dysfunction after external beam radiotherapy for prostate cancer: Results from a dose-escalation trial. Int J Radiat Oncol Biol Phys 71 (2008) 795-800
24. Selek U., Cheung R., Lii M., et al. Erectile dysfunction and radiation dose to penile base structures: A lack of correlation. Int J Radiat Oncol Biol Phys 59 (2004) 1039-1046
25. Schwartz E.J., Wong P., and Graydon R.J. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 171 (2004) 771-774
26. McCullough A.R., Levine L.A., and Padma-Nathan H. Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: Subanalysis of a longitudinal randomized double-blind placebo-controlled trial. J Sex Med 5 (2008) 476-484
27. Bannowsky A., Schulze H., van der Horst C., et al. Recovery of erectile function after nerve-sparing radical prostatectomy: Improvement with nightly low-dose sildenafil. BJU Int 101 (2008) 1279-1283
28. Padma-Nathan E., McCullough A., and Giuliano F. Postoperative nightly administration of sildenafil citrate significantly improves he return of spontaneous erectile function after bilateral nerve-sparing radical prostatectomy. J Urol 4 (2003) 375
29. Merrick G.S., Taubenslag W., Andreini H., et al. The morbidity of transperineal template-guided prostate mapping biopsy. BJU Int 101 (2008) 1524-1529
30. Cesaretti J.A., Kao J., Stone N.N., et al. Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: Analysis at > or = 7 years of follow-up. BJU Int 100 (2007) 362-367